Solara Active Pharma Sciences share price history
NSE: SOLARABSE: 541540Pharmaceuticals & BiotechnologySmall Cap
Solara Active Pharma Sciences Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2018
Last close ₹653.80up ₹17.10 (2.69%)BSE ₹653.40
Share price at the NSE close on 28 Oct 2026. Previous close ₹636.70.
28 Oct: open ₹639.80, high ₹669.00, low ₹634.90
52-week range of traded prices to 28 Oct 2026
₹422.00Low, 30 Mar 2026₹774.00High, 15 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,155 Cr1,182nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 85.40
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹10 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 66.65
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹10 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,18,30443.0% delivered
Solara Active Pharma Sciences share price by year, month and day
Closes to 28 Oct 2026; the last month as traded on NSE
Solara Active Pharma Sciences' share price is on record from 27 Jun 2018, when it closed at ₹251.75, to 28 Oct 2026. Its highest close was ₹1,810.95 on 19 May 2021 and its lowest ₹136.60 on 12 Jul 2018.
Close at year end, ₹
Adjusted close. A day's closing price restated for every split and bonus issue since, so prices years apart compare as one share held throughout: after a 1:1 bonus, earlier closes are halved. Adjusted close: how it is worked out| Year | Close at year end | Change | Highest close | Lowest close | Open | Traded high | Traded low | Volume |
|---|---|---|---|---|---|---|---|---|
| 2026so far | 653.80 | +15.7% | 753.25 | 425.55 | 564.95 | 774.00 | 422.00 | 6,46,12,664 |
| 2025 | 564.95 | −16.8% | 702.55 | 450.30 | 682.80 | 734.40 | 442.80 | 4,31,31,562 |
| 2024 | 678.80 | +88.0% | 852.40 | 359.35 | 361.05 | 882.80 | 350.00 | 7,29,30,741 |
| 2023 | 361.15 | −16.1% | 438.70 | 297.85 | 431.95 | 449.25 | 286.00 | 3,43,10,686 |
| 2022 | 430.20 | −57.8% | 1,134.60 | 327.35 | 1,035.00 | 1,215.00 | 320.00 | 4,26,68,723 |
| 2021 | 1,019.05 | −14.5% | 1,810.95 | 991.15 | 1,197.40 | 1,859.95 | 980.00 | 3,24,57,659 |
| 2020 | 1,191.55 | +174.0% | 1,303.30 | 413.10 | 430.15 | 1,341.00 | 364.35 | 2,92,88,813 |
| 2019 | 434.80 | +40.2% | 482.25 | 283.90 | 310.00 | 489.95 | 273.00 | 1,23,66,652 |
| 2018 | 310.20 | – | 382.95 | 136.60 | 265.00 | 402.05 | 134.50 | 1,39,17,638 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before; traded high and low are the year's range. 2018 is from its first session, 27 Jun 2018.
| Month | Close | Change | Open | High | Low | Volume |
|---|---|---|---|---|---|---|
| Oct 2026so far | 653.80 | −9.9% | 726.00 | 759.00 | 525.15 | 1,12,99,392 |
| Sep 2026 | 725.40 | +14.7% | 637.50 | 774.00 | 619.00 | 1,28,81,968 |
| Aug 2026 | 632.65 | +23.2% | 522.85 | 654.40 | 497.60 | 1,16,01,483 |
| Jul 2026 | 513.55 | −10.8% | 576.10 | 601.00 | 471.55 | 70,96,528 |
| Jun 2026 | 575.70 | +8.1% | 532.70 | 620.35 | 520.10 | 76,14,849 |
| May 2026 | 532.70 | +7.4% | 505.70 | 606.40 | 492.20 | 72,05,130 |
| Apr 2026 | 495.80 | +16.5% | 440.00 | 518.00 | 440.00 | 18,35,299 |
| Mar 2026 | 425.55 | −7.9% | 452.00 | 479.00 | 422.00 | 17,88,467 |
| Feb 2026 | 462.20 | −8.7% | 512.95 | 549.00 | 440.20 | 21,58,693 |
| Jan 2026 | 506.20 | −10.4% | 564.95 | 588.05 | 496.05 | 11,30,855 |
| Dec 2025 | 564.95 | +9.9% | 514.60 | 641.00 | 510.00 | 80,46,149 |
| Nov 2025 | 514.25 | −14.3% | 603.00 | 647.00 | 502.30 | 31,69,528 |
| Oct 2025 | 599.80 | −0.5% | 603.60 | 621.00 | 575.50 | 19,17,578 |
| Sep 2025 | 602.95 | −1.6% | 616.95 | 712.00 | 597.00 | 35,85,720 |
| Aug 2025 | 612.95 | −4.5% | 643.80 | 664.50 | 572.25 | 17,80,352 |
| Jul 2025 | 641.85 | +0.8% | 639.85 | 734.40 | 612.65 | 42,01,604 |
| Jun 2025 | 637.05 | +32.5% | 480.75 | 650.00 | 470.00 | 81,28,302 |
| May 2025 | 480.75 | −2.7% | 493.80 | 589.40 | 469.00 | 30,67,491 |
| Apr 2025 | 493.85 | −3.8% | 517.00 | 556.70 | 461.50 | 13,37,428 |
| Mar 2025 | 513.20 | +8.6% | 475.95 | 557.15 | 442.80 | 23,09,763 |
| Feb 2025 | 472.60 | −7.8% | 518.00 | 562.25 | 450.05 | 23,50,231 |
| Jan 2025 | 512.50 | −24.5% | 682.80 | 719.00 | 480.00 | 32,37,416 |
| Dec 2024 | 678.80 | −20.2% | 866.00 | 882.80 | 643.70 | 34,59,294 |
| Nov 2024 | 850.50 | +9.8% | 789.00 | 851.00 | 731.00 | 26,80,225 |
₹ per share, adjusted for splits and bonuses since. Change is on the close of the month before; high and low are the month's traded range.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 28 Oct 2026 | 639.80 | 669.00 | 634.90 | 653.80 | 654.25 | 2,18,304 | 43.0% |
| 27 Oct 2026 | 635.10 | 657.45 | 628.05 | 636.70 | 642.52 | 3,14,775 | 54.1% |
| 26 Oct 2026 | 608.50 | 643.00 | 604.95 | 634.55 | 631.86 | 2,42,609 | 42.8% |
| 23 Oct 2026 | 620.35 | 632.95 | 592.80 | 611.55 | 608.29 | 5,34,153 | 43.0% |
| 22 Oct 2026 | 642.70 | 659.05 | 612.55 | 619.05 | 635.75 | 4,56,451 | 37.6% |
| 21 Oct 2026 | 641.00 | 656.40 | 633.25 | 648.25 | 644.71 | 6,11,224 | 40.9% |
| 19 Oct 2026 | 708.00 | 717.45 | 641.00 | 645.65 | 674.78 | 11,26,900 | 33.5% |
| 16 Oct 2026 | 648.80 | 759.00 | 645.00 | 696.70 | 722.00 | 56,96,301 | 11.9% |
| 15 Oct 2026 | 638.00 | 665.95 | 628.25 | 648.80 | 649.50 | 2,47,765 | 51.3% |
| 14 Oct 2026 | 661.35 | 664.00 | 637.55 | 640.65 | 647.28 | 1,09,895 | 50.5% |
| 13 Oct 2026 | 662.65 | 662.65 | 643.30 | 656.60 | 653.08 | 1,28,453 | 48.8% |
| 12 Oct 2026 | 640.60 | 673.95 | 525.15 | 662.65 | 659.95 | 3,57,295 | 50.1% |
| 9 Oct 2026 | 654.00 | 666.25 | 640.10 | 644.35 | 651.46 | 1,99,638 | 40.3% |
| 8 Oct 2026 | 683.00 | 683.00 | 652.00 | 654.90 | 662.34 | 1,69,235 | 45.7% |
| 7 Oct 2026 | 682.00 | 696.00 | 680.15 | 683.70 | 687.61 | 1,54,430 | 32.8% |
| 6 Oct 2026 | 682.00 | 689.70 | 668.10 | 682.65 | 677.51 | 1,96,640 | 39.2% |
| 5 Oct 2026 | 720.00 | 724.80 | 673.10 | 676.90 | 685.61 | 2,90,504 | 43.5% |
| 1 Oct 2026 | 726.00 | 736.95 | 698.00 | 714.85 | 715.76 | 2,44,820 | 39.3% |
| 30 Sep 2026 | 759.00 | 759.00 | 720.00 | 725.40 | 738.23 | 1,77,501 | 44.3% |
| 29 Sep 2026 | 735.00 | 767.90 | 730.10 | 749.85 | 753.08 | 4,23,670 | 34.6% |
| 28 Sep 2026 | 741.70 | 750.00 | 723.75 | 736.30 | 735.94 | 2,65,881 | 35.9% |
| 25 Sep 2026 | 734.55 | 757.90 | 732.00 | 739.15 | 742.83 | 2,87,888 | 28.7% |
Prices in ₹ per share as traded, not adjusted.
Splits, bonus issues and other changes
What the prices above are adjusted for, so they read as one share held throughout.Solara Active Pharma Sciences bonus and split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 15 May 2024 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
Each event is noted and not adjusted for.